Feeding disorders in ex-prematures: causes--response to therapy--long term outcome

Gereon Schädler1, Heinz Süss-Burghart, André Michael Toschke

  • 1Kinderzentrum Munich, Institute of Social Pediatrics and Adolescent Medicine, Ludwig-Maximilians-University Munich, Heiglhofstr. 63, 81377 Munich, Germany. Gereon.Schaedler@gmx.de

Insights

Severe feeding disorders are common in ex-premature infants and often linked to developmental issues. Behavioral therapy shows sustained success in managing these challenges for many children.

Area of Science:

  • Pediatrics
  • Developmental Pediatrics
  • Rehabilitation Medicine

Background:

  • Feeding disorders present significant challenges for families of ex-premature infants.
  • These disorders can impact infant well-being and require specialized intervention.

Purpose of the Study:

  • To analyze co-morbidities, treatment response, and long-term outcomes in ex-premature infants with severe feeding disorders.
  • To identify risk factors and predictors of treatment success for feeding difficulties in this population.

Main Methods:

  • A case series analysis of 86 ex-premature infants (<37 weeks gestational age) admitted for severe feeding disorders (tube feeding or >30 min feeding times).
  • Behavioral therapy was the primary treatment modality.
  • Data collected on co-morbidities (cerebral palsy, mental retardation, interaction problems), treatment response at discharge, and long-term follow-up.

Main Results:

  • 61.6% of infants responded to treatment by discharge; tube feeding and swallowing difficulties predicted poor response.
  • Long-term follow-up (53 children) showed sustained success in 94.1%, but 25% with normal BMI at discharge later fell below the 3rd percentile.
  • Cerebral palsy (40.8%), mental retardation (51.1%), and interaction problems (87%) were common co-morbidities.

Conclusions:

  • Behavioral therapy is effective for severe feeding disorders in ex-premature infants, achieving sustained success in nearly two-thirds of cases.
  • Cerebral palsy, mental retardation, and interaction problems are significant risk factors.
  • Ongoing monitoring is crucial, as some infants may experience nutritional decline despite initial treatment success.

Related Concept Videos

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Taste Buds and Receptors01:20

Taste Buds and Receptors

Gustation, or the sense of taste, is intrinsically linked to the anatomical structures located on the tongue. This organ's surface, along with the entirety of the oral cavity, is adorned with stratified squamous epithelium. Evident on the tongue are elevated structures known as papillae (singular = papilla), which house the mechanisms for the transduction of gustatory stimuli. Four distinct types of papillae exist, each identified by their unique morphological attributes: the circumvallate,...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...